Abstract PD9-01: 5-year outcomes in the NBRST trial: Preoperative MammaPrint and BluePrint breast cancer subtype is associated with neoadjuvant treatment response and survival

Authors

Mark A. Gittleman MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

2-2021

Volume

81

Issue

4

Published In/Presented At

https://aacrjournals.org/cancerres/article/81/4_Supplement/PD9-01/648083/Abstract-PD9-01-5-year-outcomes-in-the-NBRST-trial?searchresult=1

Disciplines

Medicine and Health Sciences

Department(s)

Department of Surgery

Document Type

Article